DiaSys at ADLM 2025: Innovations and milestones

DiaSys was once again represented at ADLM, which took place from July 29th to 31st at the McCormick Place Convention Center in Chicago, USA. The event, formerly known as AACC, once again provided DiaSys an excellent platform to showcase its latest developments and products to an international audience.

Following successful exhibition appearances at Medlab Middle East 2025 and EUROMEDLAB Brussels 2025, in Chicago DiaSys continued to focus on the respons®c-line analyzer, as well as the respons®A1c and respons®UDS100, including the UDStrip-12 test strips and TruLab UriDrop controls.

A noteworthy highlight was the presentation of the latest product approval: 510(k) clearance for Procalcitonin FS by the US Food and Drug Administration (FDA). The approval obtained in collaboration with Vidan^TMdiagnostics represents another milestone in the company's success story.

Numerous discussions with existing partners, potential new customers, and interested exhibition visitors provided the DiaSys team valuable insights into the current requirements and trends in the IVD market.